Dr. Srivastava’s research has been focused on the following two parvoviruses, the non-pathogenic adeno-associated virus (AAV), and a common human pathogen, the parvovirus B19, and the development of recombinant parvovirus vectors in human gene therapy.

Principal Investigator

Arun Srivastava, PhD

Dr. Srivastava is George H. Kitzman Professor of Genetics and Chief of Division of Cellular and Molecular Therapy in the Department of Pediatrics, and Department of Molecular Genetics and Microbiology, and Powell Gene Therapy Center. He also serves as Assistant Director of the University of Florida General Clinical Research Center.

Arun Srivastava

UF Pediatric News

Running For Research – Prader-Willi Syndrome 2020

May is Prader-Willi Syndrome Awareness Month. Prader-Willi Syndrome, also known as PWS, is a rare genetic disorder affecting approximately 1 in every 15,000 people. It affects all genders and races…

AAP, CDC recommend COVID-19 vaccine for ages 12 and older

The AAP recommends adolescents ages 12 and older get vaccinated against COVID-19 now that federal health officials have signed off on the Pfizer-BioNTech vaccine for these ages.

Drs. Kelly & Thompson begin prestigious fellowship for women leaders

For UF Health pediatricians Maria N. Kelly, M.D., and Lindsay A. Thompson, M.D., medicine was always a career certainty. For years, they have embraced the special challenges of academic medicine — treating…

UF Health, Florida Department Of Health In Alachua County Address Vaccine Concerns

Dr. Kathleen Ryan, UF Health associate division chief for pediatric infectious disease, said although pregnant women were not included in the vaccine trials, the CDC is still recommending pregnant women…